Literature DB >> 11025556

Cerebral oedema during treatment of diabetic ketoacidosis: are we any nearer finding a cause?

J A Edge1.   

Abstract

Cerebral oedema remains the leading cause of death and morbidity in children with Type 1 diabetes mellitus. Around seven per thousand episodes of diabetic ketoacidosis (DKA) are complicated by cerebral oedema, and one-quarter of those children will die from it. The cause or causes of cerebral oedema are still very poorly understood, but lawyers are already keen to implicate various aspects of the management of DKA. There have been many theories as to the pathophysiology of cerebral oedema, and possible contributing factors may be excessive rate of rehydration, falling plasma osmolality (particularly that due to a reduction in plasma sodium concentration), hypoxia and insulin dosage. There is some supportive evidence for all of these factors in some cases, but there have been no sizeable case-control studies, in part because of the rarity of the condition. Furthermore, cerebral oedema can still occur even when the management of DKA follows current 'best practice' guidelines. As the mechanisms of cell volume regulation within the brain are increasingly understood, different questions may provide greater insights. For example, what is it about children that makes them so much more susceptible to cerebral oedema than adults? And why does one child treated in a certain way develop cerebral oedema whereas another does not? The anxiety over causing cerebral oedema has driven most of the changes in the management of DKA over recent decades, yet there is no evidence that the incidence has reduced. Until the causes are understood, we cannot be dogmatic about treatment recommendations. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 11025556     DOI: 10.1002/1520-7560(2000)9999:9999<::aid-dmrr143>3.0.co;2-r

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  21 in total

Review 1.  Fluid management in diabetic ketoacidosis.

Authors:  C D Inward; T L Chambers
Journal:  Arch Dis Child       Date:  2002-06       Impact factor: 3.791

2.  Change in mean transit time, apparent diffusion coefficient, and cerebral blood volume during pediatric diabetic ketoacidosis treatment.

Authors:  Monica S Vavilala; Ken I Marro; Todd L Richards; Joan S Roberts; Parichat Curry; Catherine Pihoker; Heidi Bradford; Dennis Shaw
Journal:  Pediatr Crit Care Med       Date:  2011-11       Impact factor: 3.624

Review 3.  Management of diabetic ketoacidosis.

Authors:  Neil H White
Journal:  Rev Endocr Metab Disord       Date:  2003-12       Impact factor: 6.514

4.  Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis.

Authors:  William H Hoffman; Sandra L Siedlak; Yang Wang; Rudy J Castellani; Mark A Smith
Journal:  Brain Res       Date:  2010-10-30       Impact factor: 3.252

Review 5.  Importance of timing of risk factors for cerebral oedema during therapy for diabetic ketoacidosis.

Authors:  A P C P Carlotti; D Bohn; M L Halperin
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

6.  Pediatric diabetic ketoacidosis, fluid therapy, and cerebral injury: the design of a factorial randomized controlled trial.

Authors:  Nicole S Glaser; Simona Ghetti; T Charles Casper; J Michael Dean; Nathan Kuppermann
Journal:  Pediatr Diabetes       Date:  2013-03-13       Impact factor: 4.866

7.  Change in blood-brain barrier permeability during pediatric diabetic ketoacidosis treatment.

Authors:  Monica S Vavilala; Todd L Richards; Joan S Roberts; Harvey Chiu; Catherine Pihoker; Heidi Bradford; Kristina Deeter; Ken I Marro; Dennis Shaw
Journal:  Pediatr Crit Care Med       Date:  2010-05       Impact factor: 3.624

8.  Cerebral proton magnetic resonance spectroscopy in children with diabetic ketoacidosis.

Authors:  S L Wootton-Gorges; M H Buonocore; N Kuppermann; J P Marcin; P D Barnes; E K Neely; J DiCarlo; T McCarthy; N S Glaser
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

Review 9.  ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents.

Authors:  D B Dunger; M A Sperling; C L Acerini; D J Bohn; D Daneman; T P A Danne; N S Glaser; R Hanas; R L Hintz; L L Levitsky; M O Savage; R C Tasker; J I Wolfsdorf
Journal:  Arch Dis Child       Date:  2004-02       Impact factor: 3.791

10.  Structural and ultrastructural analysis of cerebral cortex, cerebellum, and hypothalamus from diabetic rats.

Authors:  Juan P Hernández-Fonseca; Jaimar Rincón; Adriana Pedreañez; Ninoska Viera; José L Arcaya; Edgardo Carrizo; Jesús Mosquera
Journal:  Exp Diabetes Res       Date:  2009-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.